https://www.163.com/dy/article/HP9DA1GG0553TJWI.html
https://www.businesswire.com/news/home/20221221005541/en/Sunlenca%C2%AE-lenacapavir-Receives-FDA-Approval-as-a-First-in-Class-Twice-Yearly-Treatment-Option-for-People-Living-With-Multi-Drug-Resistant-HIV
估计乙肝治疗新药也快被它家突破了.